MedTrace Logo

Cystoscopic Ablation Via RF Energy Clinical Trial

NCT02398578 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2019-05-07

No results posted yet for this study

Summary

Phase I/II study to assess the safety and performance of the Amphora OAB system for treatment of urgency and frequency with or without urge incontinence caused by an overactive bladder.

Conditions

Interventions

DEVICE

Amphora OAB Device

Cystoscopic procedure to treat OAB

Sponsors & Collaborators

  • Amphora Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Roger Demochowski, MD · Vanderbilt University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • Belgium
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02398578 on ClinicalTrials.gov